GB9308802D0 - Treatment - Google Patents

Treatment

Info

Publication number
GB9308802D0
GB9308802D0 GB939308802A GB9308802A GB9308802D0 GB 9308802 D0 GB9308802 D0 GB 9308802D0 GB 939308802 A GB939308802 A GB 939308802A GB 9308802 A GB9308802 A GB 9308802A GB 9308802 D0 GB9308802 D0 GB 9308802D0
Authority
GB
United Kingdom
Prior art keywords
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB939308802A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GB939308802A priority Critical patent/GB9308802D0/en
Publication of GB9308802D0 publication Critical patent/GB9308802D0/en
Priority to PCT/EP1994/001240 priority patent/WO1994025012A2/en
Priority to AU65697/94A priority patent/AU6569794A/en
Priority to ZA942809A priority patent/ZA942809B/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB939308802A 1993-04-28 1993-04-28 Treatment Pending GB9308802D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB939308802A GB9308802D0 (en) 1993-04-28 1993-04-28 Treatment
PCT/EP1994/001240 WO1994025012A2 (en) 1993-04-28 1994-04-20 Medicaments for treatment of migraine, epilepsy and feeding disorders
AU65697/94A AU6569794A (en) 1993-04-28 1994-04-20 Medicaments for treatment of migraine, epilepsy and feeding disorders
ZA942809A ZA942809B (en) 1993-04-28 1994-04-22 Treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939308802A GB9308802D0 (en) 1993-04-28 1993-04-28 Treatment

Publications (1)

Publication Number Publication Date
GB9308802D0 true GB9308802D0 (en) 1993-06-09

Family

ID=10734635

Family Applications (1)

Application Number Title Priority Date Filing Date
GB939308802A Pending GB9308802D0 (en) 1993-04-28 1993-04-28 Treatment

Country Status (4)

Country Link
AU (1) AU6569794A (en)
GB (1) GB9308802D0 (en)
WO (1) WO1994025012A2 (en)
ZA (1) ZA942809B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5677321A (en) * 1996-02-29 1997-10-14 Synaptic Pharmaceutical Corporation 5- and 6-(2-imidazolin-2-ylamino) and -(2-thiazolin-2-ylamino)-benzothiazoles as alpha-2 adrenergic ligands
GB9700899D0 (en) * 1997-01-17 1997-03-05 Smithkline Beecham Plc Novel treatment
EP1158985B1 (en) 1999-01-13 2011-12-28 Bayer HealthCare LLC OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
PT1478358E (en) 2002-02-11 2013-09-11 Bayer Healthcare Llc Sorafenib tosylate for the treatment of diseases characterized by abnormal angiogenesis
AU2003209118A1 (en) 2002-02-11 2003-09-04 Bayer Pharmaceuticals Corporation Aryl ureas as kinase inhibitors
JP2007511203A (en) 2003-05-20 2007-05-10 バイエル、ファーマシューテイカルズ、コーポレイション Diarylurea with kinase inhibitory activity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU642041B2 (en) * 1990-09-13 1993-10-07 Beecham Group Plc Indole ureas as 5 HT receptor antagonist
WO1993018026A1 (en) * 1992-03-04 1993-09-16 Beecham Group Plc Indole ureas as 5-ht1c receptor antogonists
WO1993018028A1 (en) * 1992-03-12 1993-09-16 Smithkline Beecham Plc Indole derivatives as 5ht1c antagonists

Also Published As

Publication number Publication date
AU6569794A (en) 1994-11-21
WO1994025012A3 (en) 1994-12-22
WO1994025012A2 (en) 1994-11-10
ZA942809B (en) 1995-10-23

Similar Documents

Publication Publication Date Title
GB9411080D0 (en) Treatment
GB9215633D0 (en) Novel treatment
GB9226860D0 (en) Novel treatment
GB9203039D0 (en) Treatment
GB9211148D0 (en) Novel treatment
GB9225860D0 (en) Novel treatment
GB9226957D0 (en) Novel treatment
ZA942809B (en) Treatment
GB9226958D0 (en) Produktionsaktieselskab) novel treatment
GB2274395B (en) Massager
AP9300527A0 (en) Novel treatment
GB9203637D0 (en) Novel treatment
GB9317306D0 (en) Effluent treatment
ZA948336B (en) Treatment
GB9310836D0 (en) Treatment
GB9225859D0 (en) Novel treatment
GB9314491D0 (en) Novel treatment
GB9210596D0 (en) Treatment
GB9206395D0 (en) Treatment
GB9200361D0 (en) Treatment
GB9200360D0 (en) Treatment
GB9215903D0 (en) Treatment
GB9203249D0 (en) Treatment
GB9200359D0 (en) Treatment
GB9321591D0 (en) Novel compounds and treatment